Our Manufacturing Sites & Certifications

OUR MANUFACTURING SITES

Our global expansion is mostly covered by our two state-of-the-art manufacturing facilities, with our largest one in Rodopi being recently approved by US FDA and other national and international authorities; with a total production capacity of over 3.8bn tablets, 2.2 bn capsules, 2.5m ampoules for injection and with over 20.400m2 of manufacturing space and 5.440 m2 of warehousing space, we are ranked among the top quality manufacturers based in Europe.

At a glance

MANUFACTURING SITE SAPES RODOPI

• FDA approved
• In operation since June 2010
• Designed by German Group M&W
• 17.000 m2 in a strategic location
• New state-of-the-art facility launched in 2010
• Production capacity:
  • 3bn tablets
  • 2bn capsules
• Environmentally friendly investment
• One of the largest employers in the region

MANUFACTURING SITE PALLINI ATTICA

• 3.600 m2 Pallini plant
• 2.000 m2 Aspropyrgos warehouse
• Manufactures solid dosage forms and parenteral dosage forms
• GMP approvals
• Production capacity:
  • 800m tablets
  • 200m capsules
  • 4m amp trials for injections